Home › Kanser sa Cervix › Oklahoma
Pag-aaral pangklinika para sa Kanser sa Cervix sa Oklahoma
11 pag-aaral para sa Kanser sa Cervix ang naghahanap ng mga kalahok sa mga site sa Oklahoma.
Mga Lungsod sa Oklahoma
Opisyal na teksto ng pag-aaral (English)
A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)
- Oklahoma Cancer Specialists and Research Institute, LLC ( Site 6001), Tulsa
Nagre-recruitPhase 3
Edad 18 pataas · Kababaihan · Na-update Set 25, 2026 · NCT07216703Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer
- Oklahoma Cancer Specialists and Research Institute, LLC, Tulsa
Nagre-recruitPhase 4
Edad 18 pataas · Kababaihan · Na-update Set 25, 2026 · NCT06952660A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
- Normunity Investigational Site, Oklahoma City
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 18, 2026 · NCT07182149Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S04)
- University of Oklahoma Health Sciences Center, Oklahoma City
- University of Oklahoma, Oklahoma City
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
Edad 25 pataas · Kababaihan · Na-update Hul 31, 2026 · NCT07281430A Trial of Robotic Versus Open Hysterectomy Surgery in Cervix Cancer
- Stephenson Cancer Center, Oklahoma City
Nagre-recruit
Edad 18 pataas · Kababaihan · Na-update Hul 30, 2026 · NCT04831580A Study of Sigvotatug Vedotin in Advanced Solid Tumors
- OU Health University of Oklahoma Medical Center, Oklahoma City
- Stephenson Cancer Center (chemo location), Oklahoma City
- University of Oklahoma Health Science Center, Oklahoma City
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 6, 2026 · NCT04389632A Study to Evaluate Lenti-HPV-07 Immunotherapy Against HPV+ Cervical or Oropharyngeal Cancer
- Oklahoma Cancer Specialists and Research Institute, LLC, Tulsa
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Peb 2, 2026 · NCT06319963A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
- Dren Investigational Site, Oklahoma City
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Ene 7, 2026 · NCT06999187SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Tulsa
Nagre-recruitObservasyonal na pag-aaral
Lahat ng edad · Lahat ng kasarian · Na-update Okt 28, 2025 · NCT03452774A Phase 2 Study of Avutometinib (VS-6766) Plus Defactinib
- Stephenson Cancer Center, Oklahoma City
Nagre-recruitPhase 2
Edad 18 hanggang 99 · Kababaihan · Na-update Okt 22, 2025 · NCT05512208A Study of NX-1607 in Adults With Advanced Malignancies
- University of Oklahoma, Oklahoma City
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 9, 2025 · NCT05107674Mula sa ClinicalTrials.gov, na-kuha noong Okt 1, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.